Practical Considerations for Anticoagulation for Prevention of Venous Thromboembolism and Stroke Due to Atrial Fibrillation
WebcastFaculty
OVERVIEW
Practical Considerations for Anticoagulation for Prevention of Venous Thromboembolism and Stroke Due to Atrial Fibrillation is organized by Pri-Med and will be held during Jun 22, 2015 - Jun 22, 2018.
The target audience for this medical event is Cardiologists. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credits.
Overview :
This talk addresses prevention of stroke in patients with atrial fibrillation and the prevention and treatment of venous thromboembolism. Dr. Ruff discusses the enhanced AF risk stratification tools to assess an individual patient’s risk of stroke and bleeding and compares the relative efficacy and safety of the new anticoagulants (NOACs) with warfarin. He also reviews the management of patients with venous thromboembolism, both prevention in high-risk hospitalized patients and the treatment of patients who present with an acute DVT or PE. Learn about the different anticoagulant strategies available and review the factors that impact the duration of treatment.
Learning Objectives :
Implement appropriate risk stratification for patients with AF
Assess the risks and benefits of oral anticoagulation options for stroke prevention in patients with AF
Select and initiate an appropriate anticoagulant strategy for patients at risk for recurrent VTE
Identify high-risk medical patients for whom thromboprophylaxis should be initiated
Additional details will be posted as soon as they are available.
The target audience for this medical event is Cardiologists. This CME Conference has been approved for a maximum of 1 AMA PRA Category 1 Credits.
Overview :
This talk addresses prevention of stroke in patients with atrial fibrillation and the prevention and treatment of venous thromboembolism. Dr. Ruff discusses the enhanced AF risk stratification tools to assess an individual patient’s risk of stroke and bleeding and compares the relative efficacy and safety of the new anticoagulants (NOACs) with warfarin. He also reviews the management of patients with venous thromboembolism, both prevention in high-risk hospitalized patients and the treatment of patients who present with an acute DVT or PE. Learn about the different anticoagulant strategies available and review the factors that impact the duration of treatment.
Learning Objectives :
Implement appropriate risk stratification for patients with AF
Assess the risks and benefits of oral anticoagulation options for stroke prevention in patients with AF
Select and initiate an appropriate anticoagulant strategy for patients at risk for recurrent VTE
Identify high-risk medical patients for whom thromboprophylaxis should be initiated
Additional details will be posted as soon as they are available.
SPECIALITIES
CardiologyRELATED ONLINE COURSES
Quick Links